Elekta, world leader in advanced radiation therapy, comprehensive cancer management and noninvasive treatment of brain disorders, has announced the acquisition of 3D Line Medical Systems. Through this acquisition, Elekta adds a highly qualified R&D group specialised in stereotactic radiosurgery and dynamic IMRT treatments, as well as a product portfolio of advanced equipment and treatment planning software systems for performing radiation therapy with extreme precision and optimised dose distribution.
Subject to customary closing conditions, Elekta will pay €10 million in cash for assets in 3D Line Medical Systems (3D Line) related to radiation therapy, and up to a maximum of €8 million, based on future performance over the coming three years. Elekta expects to consolidate 3D Line into its accounts from 1 May 2007.
